Reduced blood pressure has been observed in DM patients after SGLT2 inhibition and attributed to several mechanisms, such as increased natriuresis and decreased plasma volume, arterial stiffness, and sympathetic tone [53,54,55]. This evidence concerns the gene SLC5A2 and diabetes mellitus.